Recent Developments and New Challenges in Atrial Fibrillation
A special issue of Life (ISSN 2075-1729). This special issue belongs to the section "Physiology and Pathology".
Deadline for manuscript submissions: closed (30 September 2022) | Viewed by 2686
Special Issue Editors
Interests: cardiology; cardiac electrophysiology; arrhythmias; atrial fibrillation; cardiomyopathies; ablation; new technology; conduction system pacing; sports
Interests: cardiac electrophysiology; wearables; artificial intelligence; cardiac monitoring; digital health; big data analysis
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Atrial fibrillation (AF) is the most common sustained arrhythmia, associated with significant morbidity and mortality, and it imposes important costs on health care systems. The prevalence of AF is estimated to more than double in the next decades, due to the aging population and the increasing incidence of its risk factors.
The journal Life (https://www.mdpi.com/journal/life, IF 3.817, ISSN 2075-1729) invites scientists and clinicians to contribute manuscripts to a Special Issue on “Recent Developments and New Challenges in Atrial Fibrillation”. The aim of this Special Issue is to collect cutting-edge original research papers and case reports, viewpoints as well as state-of-the-art reviews and meta-analyses, presenting recent progress toward a better understanding of pathophysiology, defining new methods for AF screening and diagnosis, and novel management options of AF. Andreas Müssigbrodt, M.D. and Alireza Sepehri Shamloo, M.D. will serve as guest editors of this Special Issue and warmly welcome all researchers to submit their related work. Suitable submissions will be warranted a fair and rapid peer review process. We look forward to your contributions in this exciting, rapidly evolving field.
Dr. Andreas Müssigbrodt
Dr. Alireza Sepehri Shamloo
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Life is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- atrial fibrillation
- AF pathophysiology
- treatment
- ablation
- diagnosis
- screening
